Comments
Loading...
AnaptysBio (ANAB) Forecast
NewsEarningsAnaptysBio (ANAB) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAnaptysBio (NASDAQ:ANAB) Stock Quotes, Forecast and News Summary
AnaptysBio Stock (NASDAQ: ANAB) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy AnaptysBio (ANAB) stock?
You can purchase shares of AnaptysBio (NASDAQ:ANAB) through any online brokerage.
Who are AnaptysBio (ANAB) competitors?
Other companies in AnaptysBio’s space includes: KalVista Pharma (NASDAQ:KALV), Celcuity (NASDAQ:CELC), Korro Bio (NASDAQ:KRRO), Monte Rosa Therapeutics (NASDAQ:GLUE) and Olema Pharmaceuticals (NASDAQ:OLMA).
What is the forecast, or price target, for AnaptysBio (ANAB) stock?
AnaptysBio has a consensus price target of $41.92.
What is the current price for AnaptysBio (ANAB)?
The stock price for AnaptysBio (NASDAQ: ANAB) is $13.8 last updated December 26, 2024 at 9:19 AM EST.
Does AnaptysBio (ANAB) pay a dividend?
There are no upcoming dividends for AnaptysBio.
When is AnaptysBio (NASDAQ:ANAB) reporting earnings?
AnaptysBio’s Q4 earnings are confirmed for Monday, March 10, 2025.
Is AnaptysBio (ANAB) going to split?
There is no upcoming split for AnaptysBio.
What sector and industry does AnaptysBio (ANAB) operate in?
AnaptysBio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.